Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts
Introduction
Diabetes is one of the major challenges for health care systems worldwide. The prevalence of type 2 diabetes is predicted to increase from 171 million in 2000 to 366 million in 2030, with the greatest increase in prevalence in those aged ≥65 years [1]. Multimorbidity, that is the presence of multiple chronic diseases, is common in the elderly population (65–80%) [2], [3], [4], further adding to the complexity of treating the elderly patient with diabetes. According to recent studies almost 75% of adults with diabetes have 2 or more comorbid conditions and these account for much of the morbidity and mortality that these patients experience [5], [6], [7].
Some comorbid diseases such as cardiovascular disease (CVD) and retinopathy, are known to be associated with diabetes due to their shared pathophysiological profile and as such are incorporated into diabetes management programs and clinical guidelines. However, there is limited guidance to facilitate the care of concomitant non-related diseases in the diabetic patient [8], and failure to adequately do so may result in ineffective control of diabetes-specific risk factors and may lead to decreased patient quality of life, functioning and potentially increased mortality risk. The major challenge for both the physician and patients is how to best integrate, coordinate and prioritise treatment strategies for all comorbidities, in addition to patient specific diabetes treatment goals [5], [9], [10].
Previous studies examining diabetes and comorbidity have looked at the effects of individual comorbid conditions [11], [12] or provided a count of numbers of conditions related to diabetes and number of independent conditions [5], [6]. Increased numbers of comorbid conditions are associated with a decreased prioritisation of diabetes and ability of patients to self-manage their disease [5], [6]. Use of diabetes-specific health services does not appear to be affected by the number of comorbid diseases [5], [6]. The prevalence of specific comorbid conditions in the elderly with diabetes is less well studied, particularly for those conditions that are not associated with diabetes. Implicit with comorbidity is the use of multiple medicines. Polypharmacy is associated with an increased risk of inappropriate prescribing and adverse drug reactions, resulting in an increase in adverse outcomes, such as falls, hospital admission and mortality [13], [14]. Importantly, the characteristics of specific comorbid conditions can potentially impact on how physicians and patients approach their care relative to their diabetes management.
The aims of this study were to investigate the prevalence of specific comorbid conditions in elderly diabetic patients and to examine the prescribing of potentially inappropriate medicines or areas of potential treatment conflicts that physicians commonly encounter in caring for elderly multimorbid diabetic patient.
Section snippets
Study sample and design
A retrospective cross-sectional study was undertaken from 1st April to 31 July 2007, which included all veterans aged 65 years and over on 1 April 2007, who had an eligible gold card (entitles veterans to full access to health services) and who had been dispensed at least one medicine for the treatment of diabetes (A10). Data were sourced from prescription dispensing records from the Department of Veterans’ Affairs (DVA), Australia. This database contains details of all prescription medicines,
Results
A total of 18,968 subjects were included in the diabetic cohort, of which 55.9% were men and 44.1% women, with a median age of 82 years (IQR 79–85) (Table 1). The median number of comorbid conditions was 5 (IQR 3–8) and the median number of unique medicines dispensed was 10 (IQR 7–14). Over 70% of the diabetic cohort were dispensed 5 or more unique medicines (Table 1).
Table 2 provides an overview of the prevalence of the number and types of anti-diabetic and cardiovascular medicines dispensed
Discussion
This large population based study show a high level of comorbidity and associated polypharmacy in elderly Australian diabetic patients. This includes both those cardiovascular comorbidities of known association with diabetes and non-related comorbid diseases. Overall 40% of the comorbidity could be attributed to associated cardiovascular conditions and 40% of all medicine use was attributed to the dispensing of diabetes guideline treatments, which includes the management of both diabetes and
Conflicts of interest
The authors declare no conflict of interest.
Acknowledgements
This work was funded by the Australian Research Council/National Health and Medical Research Council of Australia from an Ageing Well Ageing Productively Program Grant.
We thank all the Chief Investigators who collaborated with us on this project: Prof Philip Ryan, Prof Adrian Esterman and Prof Mary Luszcz.
References (46)
- et al.
Validity of medication-based comorbidity indices in the Australian elderly population Australian and New Zealand
J. Public Health
(2009) - et al.
Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers
Chest
(2005) - et al.
The association of inhaled corticosteroid use with serum glucose concentrations in a large cohort
Am. J. Med.
(2009) - et al.
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
The Lancet
(2009) - et al.
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
Diabetes Care
(2004) - et al.
Prevalence, Expenditures, and complications of multiple chronic conditions in the elderly
Arch. Intern. Med.
(2002) - et al.
Prevalence and patterns of multimorbidity in Australia
Med. J. Aust.
(2008) - et al.
Patterns of prevalent major chronic disease among older adults in the United States
JAMA
(2007) - et al.
Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients’ treatment priorities and self-management?
J. Gen. Intern. Med.
(2007) - et al.
Burden of comorbid medical conditions and quality of diabetes care
Diabetes Care
(2007)
Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors
Diabetes Care
The impact of comorbid chronic conditions on diabetes care
Diabetes Care
Using clinical guidelines designed for older adults with diabetes mellitus and complex health status
JAMA
Depression and diabetes: impact of depressive symptoms on adherence, function, and costs
Arch. Intern. Med.
Additional impact of concomitant hypertension and osteoarthritis on quality of life among patients with type 2 diabetes in primary care in Germany—a cross-sectional survey
Health Qual Life Outcomes
Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist
Drugs Aging
Prescribing for older people
BMJ
Prevalence of comorbidity of chronic diseases in Australia
BMC Public Health
Cited by (143)
COPD and multimorbidity: recognising and addressing a syndemic occurrence
2023, The Lancet Respiratory MedicineImpacts of increases and decreases of drugs on rehabilitation outcomes of subacute stroke patients
2023, Journal of Stroke and Cerebrovascular DiseasesTherapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer
2021, Advanced Drug Delivery ReviewsCitation Excerpt :Cardiovascular disease, diabetes, obesity and hypertension are all reported co-morbidities in COPD patients [11]. Approximately 10% of diabetes patients have COPD [12,13] indicating a potential relationship between the two diseases. Studies indicate that DM can worsen the disease progression in COPD patients and increase their mortality (1.62 times) [14,15].
Potential Overtreatment and Undertreatment of Type 2 Diabetes Mellitus in Long-Term Care Facilities: A Systematic Review
2021, Journal of the American Medical Directors AssociationHyperglycaemia and Chronic Obstructive Pulmonary Disease
2023, Diagnostics